Susquehanna International Group, LLP Corcept Therapeutics Inc Transaction History

Susquehanna International Group, LLP

$527 Billion
Q2 2024

A detailed history of Susquehanna International Group, LLP transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Susquehanna International Group, LLP holds 6,454 shares of CORT stock, worth $301,918. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,454

Previous 33,817 80.91%

Holding current value

$301,918

Previous $851,000 75.44%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$22.21 - $34.48 $607,732 - $943,476	-27,363 Reduced 80.91%	6,454 $209,000
Q1 2024 May 07, 2024	BUY	$21.1 - $27.46 $31,270 - $40,695	1,482 Added 4.58%	33,817 $851,000
Q4 2023 Feb 14, 2024	SELL	$24.82 - $32.88 $2.16 Million - $2.87 Million	-87,169 Reduced 72.94%	32,335 $1.05 Million
Q3 2023 Nov 14, 2023	BUY	$21.97 - $33.8 $1.14 Million - $1.75 Million	51,718 Added 76.3%	119,504 $3.26 Million
Q2 2023 Aug 11, 2023	BUY	$21.44 - $25.15 $345,033 - $404,738	16,093 Added 31.13%	67,786 $1.51 Million
Q1 2023 May 16, 2023	BUY	$19.2 - $24.47 $755,635 - $963,041	39,356 Added 319.01%	51,693 $1.12 Million
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $575,557 - $864,346	-28,850 Reduced 70.05%	12,337 $250,000
Q3 2022 Nov 14, 2022	BUY	$24.7 - $29.12 $759,623 - $895,556	30,754 Added 294.78%	41,187 $1.06 Million
Q2 2022 Aug 15, 2022	SELL	$17.33 - $25.3 $700,443 - $1.02 Million	-40,418 Reduced 79.48%	10,433 $248,000
Q1 2022 May 16, 2022	SELL	$16.53 - $25.21 $163,746 - $249,730	-9,906 Reduced 16.3%	50,851 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$17.1 - $23.34 $546,806 - $746,343	31,977 Added 111.11%	60,757 $1.2 Million
Q2 2021 Aug 11, 2021	BUY	$19.97 - $24.43 $303,444 - $371,213	15,195 Added 111.85%	28,780 $633,000
Q1 2021 May 17, 2021	SELL	$23.49 - $30.56 $1 Million - $1.31 Million	-42,776 Reduced 75.9%	13,585 $323,000
Q4 2020 Feb 16, 2021	BUY	$16.78 - $27.3 $766,392 - $1.25 Million	45,673 Added 427.33%	56,361 $1.47 Million
Q3 2020 Nov 16, 2020	SELL	$12.46 - $19.98 $199,198 - $319,420	-15,987 Reduced 59.93%	10,688 $186,000
Q1 2020 May 15, 2020	SELL	$10.11 - $14.04 $228,324 - $317,079	-22,584 Reduced 45.85%	26,675 $317,000
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $133,008 - $187,310	12,777 Added 35.02%	49,259 $696,000
Q2 2019 Aug 16, 2019	BUY	$9.78 - $12.76 $181,927 - $237,361	18,602 Added 104.04%	36,482 $407,000
Q1 2019 May 15, 2019	SELL	$10.03 - $15.71 $531,610 - $832,661	-53,002 Reduced 74.77%	17,880 $210,000
Q4 2018 Feb 14, 2019	BUY	$11.29 - $17.19 $510,443 - $777,194	45,212 Added 176.13%	70,882 $947,000
Q2 2018 Aug 14, 2018	SELL	$15.3 - $19.69 $644,252 - $829,106	-42,108 Reduced 62.13%	25,670 $404,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $833,669 - $1.31 Million	67,778	67,778 $1.31 Million

Others Institutions Holding CORT

# of Institutions

311

Shares Held

88.3M

Call Options Held

1.07M

Put Options Held

973K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.01B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Corcept Therapeutics Inc Transaction History